Neoadjuvant Docetaxel in Treating Women With Newly Diagnosed Breast Cancer
Clinical trial NCT00080626 · TERMINATED
Trial details
- NCT number
- NCT00080626
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-08-11
- Primary completion
- 2006-05-01
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.